[225Ac]Ac-DOTA-SP (TAT)

· Medical University of Warsaw

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [225Ac]Ac-DOTA-SP (TAT), covering 2025-05-16 to 2025-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression [NA]